Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma

<p>Supplementary Table 1a. Differentially expressed genes between Post-treatment vs Pre-treatment; Supplementary Table 1b. Differentially expressed genes between Responders vs Nonresponders; Supplementary Table 1c. Differentially expressed genes between PFS longer than 6 months vs PFS shorter...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
מחבר ראשי:	Tom Wei-Wu Chen (15053003) (author)
מחברים אחרים:	Chia-Lang Hsu (11929719) (author), Ruey-Long Hong (15053006) (author), Jen-Chieh Lee (14954275) (author), Koping Chang (15053009) (author), Chih-Wei Yu (15053012) (author), San-Chi Chen (15050106) (author), Jhe-Cyuan Guo (15053015) (author), Mei-Lu Chen (15053018) (author), Meng-Chi Hsu (15053021) (author), Ting-Fang Kung (15053024) (author), Ann-Lii Cheng (15045786) (author), Chueh-Chuan Yen (15053027) (author)
יצא לאור:	2025
נושאים:	Cancer Therapeutic Research and Development Clinical Research and Trials Clinical Trial Results Phase II clinical trials Sarcomas Soft-tissue sarcoma Translational Research
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma

פריטים דומים